SB

Sandu Brahmaiah

Active Director Director DIN 07470844
DIN 07470844 First appointment Apr 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2016
Shareholding value •••• Premium profile

About Sandu Brahmaiah

Data last updated:

Sandu Brahmaiah is a Director at Geokem Pharmaceuticals Private Limited (since 2016). The company operates in Pharma. Geokem Pharmaceuticals Private Limited reported revenue of ₹38.9 Lakh (FY 2020).

DIN 07470844
Primary Designation Director
Industry Pharma
First Appointment 27 Apr 2016
Oldest Company Age 10 yrs
Largest company Geokem Pharmaceuticals Private Limited · ₹38.9 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Apr 20162016₹38.9 Lakh (FY 2020)Active

Board colleagues of Sandu Brahmaiah

Directorship timeline

Open interactive timeline →
Geokem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sandu Brahmaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandu Brahmaiah

Sandu Brahmaiah currently holds 1 directorship: Geokem Pharmaceuticals Private Limited (Director, since 27 Apr 2016, revenue ₹38.9 Lakh (FY 2020)).

Sandu Brahmaiah was first appointed on 27 Apr 2016 as Director at Geokem Pharmaceuticals Private Limited.

The current boards of Sandu Brahmaiah's companies include Rafi Syed (Geokem Pharmaceuticals Private Limited), Srinivasulureddy Palem (Geokem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available